About this trial
The monocentric UZB registry for Brugada registry is intended to collect all data on patients affected by Brugada syndrome at UZ Brussel hospital (UZB).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Brugada syndrome diagnosis
Disqualifiers
Other diagnosis different from Brugada syndrome
Trial population
Brugada syndrome patients diagnosed following current guidelines: (Priori SG, Blomstrom-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 2015;36:2793-2867.) Both Brugada spontaneous type 1 and ajmaline induced will be included.
Trial design
Cohort
Prospective
Treatments tested in this trial
No intervention because it is a patient registry
Other intervention
Treatment groups
Trial outcomes
Primary outcomes
Ventricular arrhythmias
Composite of: sudden cardiac death, aborted sudden cardiac death, ventricular fibrillation, sustained ventricular tachycardia, ICD appropriate therapy
Atrial fibrillation
Atrial fibrillation occurrence
Death for any cause
Death for any cause
Cardiovascular death
Death for cardiovascular cause
Sponsors and contacts
Click on the lead sponsor to view all of their trials.